Skip to main content

Aclarion, Inc.

ACON
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001635077

In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.

Other share classesACONW

Q4 2024 vs. Q3 2024

How the institutions holding Aclarion, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ACON: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders990
Shares372.9K462.5K+89.6K (+24.0%)
Value$68.4K$66.4K−$1.96K (−2.9%)

New holders (4)

Institutions that held Aclarion, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ACON in Q4 2024
InstitutionSharesValue% of portfolio
Virtu Financial LLC146,894$21.0K0.00%
HRT Financial LP41,937$6.00K0.00%
Scientech Research LLC13,803$1.99K0.00%
FMR LLC610$880.00%

Sold out (4)

Institutions that held Aclarion, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ACON in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
UBS Group AG39,971$7.32K
Susquehanna International Group, LLP14,153$2.60K
Jane Street Group, LLC12,239$2.25K
Beaird Harris Wealth Management, LLC25$5